HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution

By Fong Abraham   Park Julie R.  

Pediatric Hematology and Oncology, Vol. 26, Iss. 8, 2009-11 ,pp. : 539-548

Informa Healthcare

Access to resources Recommend Favorite

High-Dose Busulfan and Melphalan as Conditioning Regimen for Autologous Peripheral Blood Progenitor Cell Transplantation in High-Risk Neuroblastoma Patients

By Molina Blanca   Alonso Laura   Gonzalez-Vicent Marta   Andion Maitane   Hernandez Carmen   Lassaletta Alvaro   Cormenzana Maria   Lopez-Ibor Blanca   Villa Marta   Molina Javier   Diaz Miguel A.  

Pediatric Hematology and Oncology, Vol. 28, Iss. 2, 2011-02 ,pp. : 115-123

Informa Healthcare

Access to resources Recommend Favorite

¹⁸F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma

By Piccardo Arnoldo   Lopci Egesta   Foppiani Luca   Morana Giovanni   Conte Massimo  

Pediatric Radiology, Vol. 44, Iss. 3, 2014-03 ,pp. : 355-361

Springer Publishing Company

Access to resources Recommend Favorite

LONG-TERM RESULTS OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE FOR HIGH-RISK NEUROBLASTOMA PATIENTS: A Report of the Spanish Working Party for BMT in Children (GETMON)

By Verdeguer A.   Muñoz A.   Cañete A.   Pardo N.   Martínez A.   Donat J.   Gómez P.   Bureo E.   Fernández J.   Cubells J.   Maldonado M.   Sastre A.  

Pediatric Hematology and Oncology, Vol. 21, Iss. 6, 2004-09 ,pp. : 495-502

Informa Healthcare

Access to resources Recommend Favorite

A CASE SERIES OF CHILDREN WITH HIGH-RISK METASTATIC NEUROBLASTOMA TREATED WITH A NOVEL TREATMENT STRATEGY CONSISTING OF POSTPONED PRIMARY SURGERY UNTIL THE END OF SYSTEMIC CHEMOTHERAPY INCLUDING HIGH-DOSE CHEMOTHERAPY

By Hashii Yoshiko   Kusafuka Takeshi   Ohta Hideaki   Yoneda Akihiro   Osugi Yuko   Kobayashi Yasutsugu   Fukuzawa Masahiro   Hara Junichi  

Pediatric Hematology and Oncology, Vol. 25, Iss. 5, 2008-06 ,pp. : 439-450

Informa Healthcare

Access to resources Recommend Favorite